Rupert Lanzenberger - Selected Publications#

Handbook of Clinical Neurology; Vol. 175, pages 2-459 (2020), ELSEVIER / Academic Press
Sex Differences in Neurology and Psychiatry. Edited by Rupert Lanzenberger, Georg S. Kranz, Ivanka Savic
Series Editors: Michael Aminoff, Dick F. Swaab and Francois Boller
doi: 10.1016/B978-0-444-64123-6.00013-8; www.sciencedirect.com/handbook/handbook-of-clinical-neurology/vol/175/suppl/C

Sigurdardottir HL, Kranz GS, Rami-Mark C, James GM, Vanicek T, Gryglewski G, Berroterán-Infante N, Kautzky A, Hienert M, Traub-Weidinger T, Mitterhauser M, Wadsak W, Hartmann A, Hacker M, Rujescu D, Kasper S, Lanzenberger R.
Association of norepinephrine transporter methylation with in vivo NET expression and hyperactivity-impulsivity symptoms in ADHD measured with PET. Molecular Psychiatry 2021 Mar;26(3):1009-1018. [2020, IF: 15.992]. DOI: 10.1038/s41380-019-0461-x

Vanicek T, Spies M, Rami-Mark C, Savli M, Höflich A, Kranz GS, Hahn A, Kutzelnigg A, Traub-Weidinger T, Mitterhauser M, Wadsak W, Hacker M, Volkow N, Kasper S, Lanzenberger R.
The norepinephrine transporter in attention-deficit/hyperactivity disorder investigated with positron emission tomography.
JAMA Psychiatry 2014 Dec 1;71(12):1340-9. [2020, IF: 21.596]. DOI: 10.1001/jamapsychiatry.2014.1226

Kraus C, Klöbl M, Tik M, Auer B, Vanicek T, Geissberger N, Pfabigan DM, Hahn A, Woletz M, Paul K, Komorowski A, Kasper S, Windischberger C, Lamm C, Lanzenberger R.
The pulvinar nucleus and antidepressant treatment: dynamic modeling of antidepressant response and remission with ultra-high field functional MRI. Molecular Psychiatry 2019 May;24(5):746-756. [2020, IF: 15.992]. DOI: 10.1038/s41380-017-0009-x

Lanzenberger R, Baldinger P, Hahn A, Ungersboeck J, Mitterhauser M, Winkler D, Micskei Z. Stein P, Karanikas G, Wadsak W, Kasper S, Frey R. Global decrease of serotonin-1A receptor binding after electroconvulsive therapy in major depression measured by PET.
Molecular Psychiatry 2013 Jan;18(1):93-100. [2020, IF: 15.992]. DOI: 10.1038/mp.2012.93

Kranz GS, Wadsak W, Kaufmann U, Savli M, Baldinger P, Gryglewski G, Haeusler, Spies M, Mitterhauser M, Kasper S, Lanzenberger R.
High-dose testosterone treatment increases serotonin transporter binding in transgender people.
Biological Psychiatry 2015 Oct 15;78(8):525-33. [2020, IF: 13.382]. DOI: 10.1016/j.biopsych.2014.09.010

Hahn A, Wadsak W, Windischberger C, Baldinger P, Höflich A, Losak J, Nics L, Philippe C, Kranz GS, Kraus C, Mitterhauser M, Karanikas G, Kasper S, Lanzenberger R. Differential modulation of the default mode network via serotonin-1A receptors.
Proceedings of the National Academy of Sciences USA (PNAS) 2012 Feb 14;109(7):2619-24.[2020, IF: 11.205]

Rischka L, Vraka C, Pichler V, Rasul S, Nics L, Gryglewski G, Handschuh PA, Murgas M, Godbersen GM, Silberbauer L, Unterholzner J, Wotawa C, Haider A, Ahmed H, Schibli R, Mindt T, Mitterhauser M, Wadsak W, Hahn A, Lanzenberger R#, Hacker M#, Ametamey S#. (#corresponding author).
First-in-human brain PET imaging of the GluN2B-containing N-methyl-D-aspartate receptor with (R)-11C-Me-NB1. (NMDA)
Journal of Nuclear Medicine 2021 Oct 7:jnumed.121.262427 [2020, IF: 10.057]; DOI: 10.2967/jnumed.121.262427

Hahn A, Gryglewski G, Nics L, Hienert M, Rischka L, Vraka C, Sigurdardottir H, Vanicek T, James GM, Seiger R, Kautzky A, Silberbauer L, Wadsak W, Mitterhauser M, Hacker M, Kasper S, Lanzenberger R.
Quantification of task-specific glucose metabolism with constant infusion of [18F]FDG.
Journal of Nuclear Medicine 2016 Dec;57(12):1933-1940. Epub 2016 Jul 7 [2020, IF: 10.057]. DOI: 10.2967/jnumed.116.176156

Gryglewski G, Baldinger-Melich P, Seiger R, Godbersen GM, Michenthaler P, Klöbl M, Spurny B, Kautzky A, Vanicek T, Kasper S, Frey R, Lanzenberger R. Structural changes in amygdala nuclei, hippocampal subfields and cortical thickness following electroconvulsive therapy in treatment resistant depression: longitudinal analysis.
British Journal of Psychiatry 2019; 214(3):159-167. [2020, IF: 9.319]. DOI: 10.1192/bjp.2018.224